Selecionar segmento
Estude com questões de diferentes segmentos
Atenção: Isso limpará todos os campos já preenchidos no filtro!
Foram encontradas 1.266 questões
Resolva questões gratuitamente!
Junte-se a mais de 4 milhões de concurseiros!
Ano: 2003
Banca:
FCC
Órgão:
CVM
Prova:
FCC - 2003 - CVM - Analista - Normas Contábeis e de Auditoria |
Q2243764
Inglês
Texto associado
Michael R. Bloomberg is the 108th Mayor of the City of
New York. He was born on February 14, 1942 to middle class
parents in Medford, Massachusetts, where his father was the
bookkeeper at a local dairy. Mayor Bloomberg's thirst for
information and fascination with technology was evident at an
early age, and led him to Johns Hopkins University, where he
parked cars and took out loans to finance his education. After
his college graduation, he gained an MBA from Harvard and in
the summer of 1966, he was hired by Salomon Brothers to work
on Wall Street.
He quickly advanced through the ranks, and became a
partner in 1972. Soon after, he was supervising all of Salomon's
stock trading, sales and later, its information systems. He was
fired in 1981 after another company acquired Salomon. Michael
Bloomberg used his stake from the Salomon sale to start his
...39... company, an endeavor that would revolutionize the way
that Wall Street ....40.... business. As a young trader, he had been
amazed at the archaic nature in which information was stored.
When he needed to see how a stock had been trading three
weeks earlier, he had to find a copy of the Wall Street Journal
from the date in question, and the records system consisted of
clerks penciling trades in oversize ledgers. ...41... , he created a
financial information computer that would collect and analyze
different combinations of past and present securities data and
deliver it immediately to the user.
In 1982, Bloomberg LP sold 20 subscriptions to its
service; 20 years ....42... , Bloomberg LP has over 165,000
subscribers worldwide. As the business proved its viability, the company branched out and in 1990 Bloomberg LP entered the
media business, launching a news service, and then radio,
television, Internet, and publishing operations.
Nearly 20 years after its founding, Bloomberg LP now
employs more than 8,000 people − including 2,500 in New York
City − in more than 100 offices worldwide. As the company
enjoyed tremendous growth, Michael Bloomberg dedicated more
of his time and energy to philanthropy and civic affairs. His
desire to improve education, advance medical research and
increase access to the arts, has provided the motivation for
much of his philanthropy.
The Mayor served as the Chairman of the Board of
Trustees of Johns Hopkins University until May 2002. Recently,
he was honored by Johns Hopkins University, when its School of
Hygiene and Public Health was renamed "The Bloomberg
School of Public Health," a tribute to his leadership and use of
philanthropy to improve the human ....43... .
In 1997, Michael Bloomberg published his autobiography,
Bloomberg by Bloomberg. All of the royalties from sales of the
book are donated to the Committee to Protect Journalists.
(Adapted from
http://home.nyc.gov/portal/index.jsp?pageID=nyc_mayor_bio&catID=119
4&cc=unused1196&rc=1194&ndi=-1)
Which of the following does NOT apply to Michael
Bloomberg?
Ano: 2003
Banca:
FCC
Órgão:
CVM
Prova:
FCC - 2003 - CVM - Analista - Normas Contábeis e de Auditoria |
Q2243763
Inglês
Texto associado
Michael R. Bloomberg is the 108th Mayor of the City of
New York. He was born on February 14, 1942 to middle class
parents in Medford, Massachusetts, where his father was the
bookkeeper at a local dairy. Mayor Bloomberg's thirst for
information and fascination with technology was evident at an
early age, and led him to Johns Hopkins University, where he
parked cars and took out loans to finance his education. After
his college graduation, he gained an MBA from Harvard and in
the summer of 1966, he was hired by Salomon Brothers to work
on Wall Street.
He quickly advanced through the ranks, and became a
partner in 1972. Soon after, he was supervising all of Salomon's
stock trading, sales and later, its information systems. He was
fired in 1981 after another company acquired Salomon. Michael
Bloomberg used his stake from the Salomon sale to start his
...39... company, an endeavor that would revolutionize the way
that Wall Street ....40.... business. As a young trader, he had been
amazed at the archaic nature in which information was stored.
When he needed to see how a stock had been trading three
weeks earlier, he had to find a copy of the Wall Street Journal
from the date in question, and the records system consisted of
clerks penciling trades in oversize ledgers. ...41... , he created a
financial information computer that would collect and analyze
different combinations of past and present securities data and
deliver it immediately to the user.
In 1982, Bloomberg LP sold 20 subscriptions to its
service; 20 years ....42... , Bloomberg LP has over 165,000
subscribers worldwide. As the business proved its viability, the company branched out and in 1990 Bloomberg LP entered the
media business, launching a news service, and then radio,
television, Internet, and publishing operations.
Nearly 20 years after its founding, Bloomberg LP now
employs more than 8,000 people − including 2,500 in New York
City − in more than 100 offices worldwide. As the company
enjoyed tremendous growth, Michael Bloomberg dedicated more
of his time and energy to philanthropy and civic affairs. His
desire to improve education, advance medical research and
increase access to the arts, has provided the motivation for
much of his philanthropy.
The Mayor served as the Chairman of the Board of
Trustees of Johns Hopkins University until May 2002. Recently,
he was honored by Johns Hopkins University, when its School of
Hygiene and Public Health was renamed "The Bloomberg
School of Public Health," a tribute to his leadership and use of
philanthropy to improve the human ....43... .
In 1997, Michael Bloomberg published his autobiography,
Bloomberg by Bloomberg. All of the royalties from sales of the
book are donated to the Committee to Protect Journalists.
(Adapted from
http://home.nyc.gov/portal/index.jsp?pageID=nyc_mayor_bio&catID=119
4&cc=unused1196&rc=1194&ndi=-1)
De acordo com o texto, a Bloomberg LP
Ano: 2003
Banca:
FCC
Órgão:
CVM
Prova:
FCC - 2003 - CVM - Analista - Normas Contábeis e de Auditoria |
Q2243762
Inglês
Texto associado
Michael R. Bloomberg is the 108th Mayor of the City of
New York. He was born on February 14, 1942 to middle class
parents in Medford, Massachusetts, where his father was the
bookkeeper at a local dairy. Mayor Bloomberg's thirst for
information and fascination with technology was evident at an
early age, and led him to Johns Hopkins University, where he
parked cars and took out loans to finance his education. After
his college graduation, he gained an MBA from Harvard and in
the summer of 1966, he was hired by Salomon Brothers to work
on Wall Street.
He quickly advanced through the ranks, and became a
partner in 1972. Soon after, he was supervising all of Salomon's
stock trading, sales and later, its information systems. He was
fired in 1981 after another company acquired Salomon. Michael
Bloomberg used his stake from the Salomon sale to start his
...39... company, an endeavor that would revolutionize the way
that Wall Street ....40.... business. As a young trader, he had been
amazed at the archaic nature in which information was stored.
When he needed to see how a stock had been trading three
weeks earlier, he had to find a copy of the Wall Street Journal
from the date in question, and the records system consisted of
clerks penciling trades in oversize ledgers. ...41... , he created a
financial information computer that would collect and analyze
different combinations of past and present securities data and
deliver it immediately to the user.
In 1982, Bloomberg LP sold 20 subscriptions to its
service; 20 years ....42... , Bloomberg LP has over 165,000
subscribers worldwide. As the business proved its viability, the company branched out and in 1990 Bloomberg LP entered the
media business, launching a news service, and then radio,
television, Internet, and publishing operations.
Nearly 20 years after its founding, Bloomberg LP now
employs more than 8,000 people − including 2,500 in New York
City − in more than 100 offices worldwide. As the company
enjoyed tremendous growth, Michael Bloomberg dedicated more
of his time and energy to philanthropy and civic affairs. His
desire to improve education, advance medical research and
increase access to the arts, has provided the motivation for
much of his philanthropy.
The Mayor served as the Chairman of the Board of
Trustees of Johns Hopkins University until May 2002. Recently,
he was honored by Johns Hopkins University, when its School of
Hygiene and Public Health was renamed "The Bloomberg
School of Public Health," a tribute to his leadership and use of
philanthropy to improve the human ....43... .
In 1997, Michael Bloomberg published his autobiography,
Bloomberg by Bloomberg. All of the royalties from sales of the
book are donated to the Committee to Protect Journalists.
(Adapted from
http://home.nyc.gov/portal/index.jsp?pageID=nyc_mayor_bio&catID=119
4&cc=unused1196&rc=1194&ndi=-1)
Segundo o texto, quando Michael Bloomberg começou a
atuar em Wall Street
Ano: 2003
Banca:
FCC
Órgão:
CVM
Prova:
FCC - 2003 - CVM - Analista - Normas Contábeis e de Auditoria |
Q2243761
Inglês
Texto associado
Michael R. Bloomberg is the 108th Mayor of the City of
New York. He was born on February 14, 1942 to middle class
parents in Medford, Massachusetts, where his father was the
bookkeeper at a local dairy. Mayor Bloomberg's thirst for
information and fascination with technology was evident at an
early age, and led him to Johns Hopkins University, where he
parked cars and took out loans to finance his education. After
his college graduation, he gained an MBA from Harvard and in
the summer of 1966, he was hired by Salomon Brothers to work
on Wall Street.
He quickly advanced through the ranks, and became a
partner in 1972. Soon after, he was supervising all of Salomon's
stock trading, sales and later, its information systems. He was
fired in 1981 after another company acquired Salomon. Michael
Bloomberg used his stake from the Salomon sale to start his
...39... company, an endeavor that would revolutionize the way
that Wall Street ....40.... business. As a young trader, he had been
amazed at the archaic nature in which information was stored.
When he needed to see how a stock had been trading three
weeks earlier, he had to find a copy of the Wall Street Journal
from the date in question, and the records system consisted of
clerks penciling trades in oversize ledgers. ...41... , he created a
financial information computer that would collect and analyze
different combinations of past and present securities data and
deliver it immediately to the user.
In 1982, Bloomberg LP sold 20 subscriptions to its
service; 20 years ....42... , Bloomberg LP has over 165,000
subscribers worldwide. As the business proved its viability, the company branched out and in 1990 Bloomberg LP entered the
media business, launching a news service, and then radio,
television, Internet, and publishing operations.
Nearly 20 years after its founding, Bloomberg LP now
employs more than 8,000 people − including 2,500 in New York
City − in more than 100 offices worldwide. As the company
enjoyed tremendous growth, Michael Bloomberg dedicated more
of his time and energy to philanthropy and civic affairs. His
desire to improve education, advance medical research and
increase access to the arts, has provided the motivation for
much of his philanthropy.
The Mayor served as the Chairman of the Board of
Trustees of Johns Hopkins University until May 2002. Recently,
he was honored by Johns Hopkins University, when its School of
Hygiene and Public Health was renamed "The Bloomberg
School of Public Health," a tribute to his leadership and use of
philanthropy to improve the human ....43... .
In 1997, Michael Bloomberg published his autobiography,
Bloomberg by Bloomberg. All of the royalties from sales of the
book are donated to the Committee to Protect Journalists.
(Adapted from
http://home.nyc.gov/portal/index.jsp?pageID=nyc_mayor_bio&catID=119
4&cc=unused1196&rc=1194&ndi=-1)
Segundo o texto, Bloomberg
Ano: 2003
Banca:
FCC
Órgão:
CVM
Prova:
FCC - 2003 - CVM - Analista - Normas Contábeis e de Auditoria |
Q2243760
Inglês
Texto associado
Michael R. Bloomberg is the 108th Mayor of the City of
New York. He was born on February 14, 1942 to middle class
parents in Medford, Massachusetts, where his father was the
bookkeeper at a local dairy. Mayor Bloomberg's thirst for
information and fascination with technology was evident at an
early age, and led him to Johns Hopkins University, where he
parked cars and took out loans to finance his education. After
his college graduation, he gained an MBA from Harvard and in
the summer of 1966, he was hired by Salomon Brothers to work
on Wall Street.
He quickly advanced through the ranks, and became a
partner in 1972. Soon after, he was supervising all of Salomon's
stock trading, sales and later, its information systems. He was
fired in 1981 after another company acquired Salomon. Michael
Bloomberg used his stake from the Salomon sale to start his
...39... company, an endeavor that would revolutionize the way
that Wall Street ....40.... business. As a young trader, he had been
amazed at the archaic nature in which information was stored.
When he needed to see how a stock had been trading three
weeks earlier, he had to find a copy of the Wall Street Journal
from the date in question, and the records system consisted of
clerks penciling trades in oversize ledgers. ...41... , he created a
financial information computer that would collect and analyze
different combinations of past and present securities data and
deliver it immediately to the user.
In 1982, Bloomberg LP sold 20 subscriptions to its
service; 20 years ....42... , Bloomberg LP has over 165,000
subscribers worldwide. As the business proved its viability, the company branched out and in 1990 Bloomberg LP entered the
media business, launching a news service, and then radio,
television, Internet, and publishing operations.
Nearly 20 years after its founding, Bloomberg LP now
employs more than 8,000 people − including 2,500 in New York
City − in more than 100 offices worldwide. As the company
enjoyed tremendous growth, Michael Bloomberg dedicated more
of his time and energy to philanthropy and civic affairs. His
desire to improve education, advance medical research and
increase access to the arts, has provided the motivation for
much of his philanthropy.
The Mayor served as the Chairman of the Board of
Trustees of Johns Hopkins University until May 2002. Recently,
he was honored by Johns Hopkins University, when its School of
Hygiene and Public Health was renamed "The Bloomberg
School of Public Health," a tribute to his leadership and use of
philanthropy to improve the human ....43... .
In 1997, Michael Bloomberg published his autobiography,
Bloomberg by Bloomberg. All of the royalties from sales of the
book are donated to the Committee to Protect Journalists.
(Adapted from
http://home.nyc.gov/portal/index.jsp?pageID=nyc_mayor_bio&catID=119
4&cc=unused1196&rc=1194&ndi=-1)
In the text, 5th paragraph, the underlined pronoun its refers
to
Ano: 2003
Banca:
FCC
Órgão:
CVM
Prova:
FCC - 2003 - CVM - Analista - Normas Contábeis e de Auditoria |
Q2243759
Inglês
Texto associado
Michael R. Bloomberg is the 108th Mayor of the City of
New York. He was born on February 14, 1942 to middle class
parents in Medford, Massachusetts, where his father was the
bookkeeper at a local dairy. Mayor Bloomberg's thirst for
information and fascination with technology was evident at an
early age, and led him to Johns Hopkins University, where he
parked cars and took out loans to finance his education. After
his college graduation, he gained an MBA from Harvard and in
the summer of 1966, he was hired by Salomon Brothers to work
on Wall Street.
He quickly advanced through the ranks, and became a
partner in 1972. Soon after, he was supervising all of Salomon's
stock trading, sales and later, its information systems. He was
fired in 1981 after another company acquired Salomon. Michael
Bloomberg used his stake from the Salomon sale to start his
...39... company, an endeavor that would revolutionize the way
that Wall Street ....40.... business. As a young trader, he had been
amazed at the archaic nature in which information was stored.
When he needed to see how a stock had been trading three
weeks earlier, he had to find a copy of the Wall Street Journal
from the date in question, and the records system consisted of
clerks penciling trades in oversize ledgers. ...41... , he created a
financial information computer that would collect and analyze
different combinations of past and present securities data and
deliver it immediately to the user.
In 1982, Bloomberg LP sold 20 subscriptions to its
service; 20 years ....42... , Bloomberg LP has over 165,000
subscribers worldwide. As the business proved its viability, the company branched out and in 1990 Bloomberg LP entered the
media business, launching a news service, and then radio,
television, Internet, and publishing operations.
Nearly 20 years after its founding, Bloomberg LP now
employs more than 8,000 people − including 2,500 in New York
City − in more than 100 offices worldwide. As the company
enjoyed tremendous growth, Michael Bloomberg dedicated more
of his time and energy to philanthropy and civic affairs. His
desire to improve education, advance medical research and
increase access to the arts, has provided the motivation for
much of his philanthropy.
The Mayor served as the Chairman of the Board of
Trustees of Johns Hopkins University until May 2002. Recently,
he was honored by Johns Hopkins University, when its School of
Hygiene and Public Health was renamed "The Bloomberg
School of Public Health," a tribute to his leadership and use of
philanthropy to improve the human ....43... .
In 1997, Michael Bloomberg published his autobiography,
Bloomberg by Bloomberg. All of the royalties from sales of the
book are donated to the Committee to Protect Journalists.
(Adapted from
http://home.nyc.gov/portal/index.jsp?pageID=nyc_mayor_bio&catID=119
4&cc=unused1196&rc=1194&ndi=-1)
No texto, advanced through the ranks refere-se à rapidez
com que Bloomberg
Ano: 2003
Banca:
FCC
Órgão:
CVM
Prova:
FCC - 2003 - CVM - Analista - Normas Contábeis e de Auditoria |
Q2243758
Inglês
Texto associado
Michael R. Bloomberg is the 108th Mayor of the City of
New York. He was born on February 14, 1942 to middle class
parents in Medford, Massachusetts, where his father was the
bookkeeper at a local dairy. Mayor Bloomberg's thirst for
information and fascination with technology was evident at an
early age, and led him to Johns Hopkins University, where he
parked cars and took out loans to finance his education. After
his college graduation, he gained an MBA from Harvard and in
the summer of 1966, he was hired by Salomon Brothers to work
on Wall Street.
He quickly advanced through the ranks, and became a
partner in 1972. Soon after, he was supervising all of Salomon's
stock trading, sales and later, its information systems. He was
fired in 1981 after another company acquired Salomon. Michael
Bloomberg used his stake from the Salomon sale to start his
...39... company, an endeavor that would revolutionize the way
that Wall Street ....40.... business. As a young trader, he had been
amazed at the archaic nature in which information was stored.
When he needed to see how a stock had been trading three
weeks earlier, he had to find a copy of the Wall Street Journal
from the date in question, and the records system consisted of
clerks penciling trades in oversize ledgers. ...41... , he created a
financial information computer that would collect and analyze
different combinations of past and present securities data and
deliver it immediately to the user.
In 1982, Bloomberg LP sold 20 subscriptions to its
service; 20 years ....42... , Bloomberg LP has over 165,000
subscribers worldwide. As the business proved its viability, the company branched out and in 1990 Bloomberg LP entered the
media business, launching a news service, and then radio,
television, Internet, and publishing operations.
Nearly 20 years after its founding, Bloomberg LP now
employs more than 8,000 people − including 2,500 in New York
City − in more than 100 offices worldwide. As the company
enjoyed tremendous growth, Michael Bloomberg dedicated more
of his time and energy to philanthropy and civic affairs. His
desire to improve education, advance medical research and
increase access to the arts, has provided the motivation for
much of his philanthropy.
The Mayor served as the Chairman of the Board of
Trustees of Johns Hopkins University until May 2002. Recently,
he was honored by Johns Hopkins University, when its School of
Hygiene and Public Health was renamed "The Bloomberg
School of Public Health," a tribute to his leadership and use of
philanthropy to improve the human ....43... .
In 1997, Michael Bloomberg published his autobiography,
Bloomberg by Bloomberg. All of the royalties from sales of the
book are donated to the Committee to Protect Journalists.
(Adapted from
http://home.nyc.gov/portal/index.jsp?pageID=nyc_mayor_bio&catID=119
4&cc=unused1196&rc=1194&ndi=-1)
Para responder à questão, assinale, na folha de respostas, a letra correspondente à alternativa que preencha corretamente a lacuna do texto apresentado (...43...).
Ano: 2003
Banca:
FCC
Órgão:
CVM
Prova:
FCC - 2003 - CVM - Analista - Normas Contábeis e de Auditoria |
Q2243757
Inglês
Texto associado
Michael R. Bloomberg is the 108th Mayor of the City of
New York. He was born on February 14, 1942 to middle class
parents in Medford, Massachusetts, where his father was the
bookkeeper at a local dairy. Mayor Bloomberg's thirst for
information and fascination with technology was evident at an
early age, and led him to Johns Hopkins University, where he
parked cars and took out loans to finance his education. After
his college graduation, he gained an MBA from Harvard and in
the summer of 1966, he was hired by Salomon Brothers to work
on Wall Street.
He quickly advanced through the ranks, and became a
partner in 1972. Soon after, he was supervising all of Salomon's
stock trading, sales and later, its information systems. He was
fired in 1981 after another company acquired Salomon. Michael
Bloomberg used his stake from the Salomon sale to start his
...39... company, an endeavor that would revolutionize the way
that Wall Street ....40.... business. As a young trader, he had been
amazed at the archaic nature in which information was stored.
When he needed to see how a stock had been trading three
weeks earlier, he had to find a copy of the Wall Street Journal
from the date in question, and the records system consisted of
clerks penciling trades in oversize ledgers. ...41... , he created a
financial information computer that would collect and analyze
different combinations of past and present securities data and
deliver it immediately to the user.
In 1982, Bloomberg LP sold 20 subscriptions to its
service; 20 years ....42... , Bloomberg LP has over 165,000
subscribers worldwide. As the business proved its viability, the company branched out and in 1990 Bloomberg LP entered the
media business, launching a news service, and then radio,
television, Internet, and publishing operations.
Nearly 20 years after its founding, Bloomberg LP now
employs more than 8,000 people − including 2,500 in New York
City − in more than 100 offices worldwide. As the company
enjoyed tremendous growth, Michael Bloomberg dedicated more
of his time and energy to philanthropy and civic affairs. His
desire to improve education, advance medical research and
increase access to the arts, has provided the motivation for
much of his philanthropy.
The Mayor served as the Chairman of the Board of
Trustees of Johns Hopkins University until May 2002. Recently,
he was honored by Johns Hopkins University, when its School of
Hygiene and Public Health was renamed "The Bloomberg
School of Public Health," a tribute to his leadership and use of
philanthropy to improve the human ....43... .
In 1997, Michael Bloomberg published his autobiography,
Bloomberg by Bloomberg. All of the royalties from sales of the
book are donated to the Committee to Protect Journalists.
(Adapted from
http://home.nyc.gov/portal/index.jsp?pageID=nyc_mayor_bio&catID=119
4&cc=unused1196&rc=1194&ndi=-1)
Para responder à questão, assinale, na folha de respostas, a letra correspondente à alternativa que preencha corretamente a lacuna do texto apresentado (...42...).
Ano: 2003
Banca:
FCC
Órgão:
CVM
Prova:
FCC - 2003 - CVM - Analista - Normas Contábeis e de Auditoria |
Q2243756
Inglês
Texto associado
Michael R. Bloomberg is the 108th Mayor of the City of
New York. He was born on February 14, 1942 to middle class
parents in Medford, Massachusetts, where his father was the
bookkeeper at a local dairy. Mayor Bloomberg's thirst for
information and fascination with technology was evident at an
early age, and led him to Johns Hopkins University, where he
parked cars and took out loans to finance his education. After
his college graduation, he gained an MBA from Harvard and in
the summer of 1966, he was hired by Salomon Brothers to work
on Wall Street.
He quickly advanced through the ranks, and became a
partner in 1972. Soon after, he was supervising all of Salomon's
stock trading, sales and later, its information systems. He was
fired in 1981 after another company acquired Salomon. Michael
Bloomberg used his stake from the Salomon sale to start his
...39... company, an endeavor that would revolutionize the way
that Wall Street ....40.... business. As a young trader, he had been
amazed at the archaic nature in which information was stored.
When he needed to see how a stock had been trading three
weeks earlier, he had to find a copy of the Wall Street Journal
from the date in question, and the records system consisted of
clerks penciling trades in oversize ledgers. ...41... , he created a
financial information computer that would collect and analyze
different combinations of past and present securities data and
deliver it immediately to the user.
In 1982, Bloomberg LP sold 20 subscriptions to its
service; 20 years ....42... , Bloomberg LP has over 165,000
subscribers worldwide. As the business proved its viability, the company branched out and in 1990 Bloomberg LP entered the
media business, launching a news service, and then radio,
television, Internet, and publishing operations.
Nearly 20 years after its founding, Bloomberg LP now
employs more than 8,000 people − including 2,500 in New York
City − in more than 100 offices worldwide. As the company
enjoyed tremendous growth, Michael Bloomberg dedicated more
of his time and energy to philanthropy and civic affairs. His
desire to improve education, advance medical research and
increase access to the arts, has provided the motivation for
much of his philanthropy.
The Mayor served as the Chairman of the Board of
Trustees of Johns Hopkins University until May 2002. Recently,
he was honored by Johns Hopkins University, when its School of
Hygiene and Public Health was renamed "The Bloomberg
School of Public Health," a tribute to his leadership and use of
philanthropy to improve the human ....43... .
In 1997, Michael Bloomberg published his autobiography,
Bloomberg by Bloomberg. All of the royalties from sales of the
book are donated to the Committee to Protect Journalists.
(Adapted from
http://home.nyc.gov/portal/index.jsp?pageID=nyc_mayor_bio&catID=119
4&cc=unused1196&rc=1194&ndi=-1)
Para responder à questão, assinale, na folha de respostas, a letra correspondente à alternativa que preencha corretamente a lacuna do texto apresentado (...41...).
Ano: 2003
Banca:
FCC
Órgão:
CVM
Prova:
FCC - 2003 - CVM - Analista - Normas Contábeis e de Auditoria |
Q2243755
Inglês
Texto associado
Michael R. Bloomberg is the 108th Mayor of the City of
New York. He was born on February 14, 1942 to middle class
parents in Medford, Massachusetts, where his father was the
bookkeeper at a local dairy. Mayor Bloomberg's thirst for
information and fascination with technology was evident at an
early age, and led him to Johns Hopkins University, where he
parked cars and took out loans to finance his education. After
his college graduation, he gained an MBA from Harvard and in
the summer of 1966, he was hired by Salomon Brothers to work
on Wall Street.
He quickly advanced through the ranks, and became a
partner in 1972. Soon after, he was supervising all of Salomon's
stock trading, sales and later, its information systems. He was
fired in 1981 after another company acquired Salomon. Michael
Bloomberg used his stake from the Salomon sale to start his
...39... company, an endeavor that would revolutionize the way
that Wall Street ....40.... business. As a young trader, he had been
amazed at the archaic nature in which information was stored.
When he needed to see how a stock had been trading three
weeks earlier, he had to find a copy of the Wall Street Journal
from the date in question, and the records system consisted of
clerks penciling trades in oversize ledgers. ...41... , he created a
financial information computer that would collect and analyze
different combinations of past and present securities data and
deliver it immediately to the user.
In 1982, Bloomberg LP sold 20 subscriptions to its
service; 20 years ....42... , Bloomberg LP has over 165,000
subscribers worldwide. As the business proved its viability, the company branched out and in 1990 Bloomberg LP entered the
media business, launching a news service, and then radio,
television, Internet, and publishing operations.
Nearly 20 years after its founding, Bloomberg LP now
employs more than 8,000 people − including 2,500 in New York
City − in more than 100 offices worldwide. As the company
enjoyed tremendous growth, Michael Bloomberg dedicated more
of his time and energy to philanthropy and civic affairs. His
desire to improve education, advance medical research and
increase access to the arts, has provided the motivation for
much of his philanthropy.
The Mayor served as the Chairman of the Board of
Trustees of Johns Hopkins University until May 2002. Recently,
he was honored by Johns Hopkins University, when its School of
Hygiene and Public Health was renamed "The Bloomberg
School of Public Health," a tribute to his leadership and use of
philanthropy to improve the human ....43... .
In 1997, Michael Bloomberg published his autobiography,
Bloomberg by Bloomberg. All of the royalties from sales of the
book are donated to the Committee to Protect Journalists.
(Adapted from
http://home.nyc.gov/portal/index.jsp?pageID=nyc_mayor_bio&catID=119
4&cc=unused1196&rc=1194&ndi=-1)
Para responder à questão, assinale, na folha de respostas, a letra correspondente à alternativa que preencha corretamente a lacuna do texto apresentado (...40...).
Ano: 2003
Banca:
FCC
Órgão:
CVM
Prova:
FCC - 2003 - CVM - Analista - Normas Contábeis e de Auditoria |
Q2243754
Inglês
Texto associado
Michael R. Bloomberg is the 108th Mayor of the City of
New York. He was born on February 14, 1942 to middle class
parents in Medford, Massachusetts, where his father was the
bookkeeper at a local dairy. Mayor Bloomberg's thirst for
information and fascination with technology was evident at an
early age, and led him to Johns Hopkins University, where he
parked cars and took out loans to finance his education. After
his college graduation, he gained an MBA from Harvard and in
the summer of 1966, he was hired by Salomon Brothers to work
on Wall Street.
He quickly advanced through the ranks, and became a
partner in 1972. Soon after, he was supervising all of Salomon's
stock trading, sales and later, its information systems. He was
fired in 1981 after another company acquired Salomon. Michael
Bloomberg used his stake from the Salomon sale to start his
...39... company, an endeavor that would revolutionize the way
that Wall Street ....40.... business. As a young trader, he had been
amazed at the archaic nature in which information was stored.
When he needed to see how a stock had been trading three
weeks earlier, he had to find a copy of the Wall Street Journal
from the date in question, and the records system consisted of
clerks penciling trades in oversize ledgers. ...41... , he created a
financial information computer that would collect and analyze
different combinations of past and present securities data and
deliver it immediately to the user.
In 1982, Bloomberg LP sold 20 subscriptions to its
service; 20 years ....42... , Bloomberg LP has over 165,000
subscribers worldwide. As the business proved its viability, the company branched out and in 1990 Bloomberg LP entered the
media business, launching a news service, and then radio,
television, Internet, and publishing operations.
Nearly 20 years after its founding, Bloomberg LP now
employs more than 8,000 people − including 2,500 in New York
City − in more than 100 offices worldwide. As the company
enjoyed tremendous growth, Michael Bloomberg dedicated more
of his time and energy to philanthropy and civic affairs. His
desire to improve education, advance medical research and
increase access to the arts, has provided the motivation for
much of his philanthropy.
The Mayor served as the Chairman of the Board of
Trustees of Johns Hopkins University until May 2002. Recently,
he was honored by Johns Hopkins University, when its School of
Hygiene and Public Health was renamed "The Bloomberg
School of Public Health," a tribute to his leadership and use of
philanthropy to improve the human ....43... .
In 1997, Michael Bloomberg published his autobiography,
Bloomberg by Bloomberg. All of the royalties from sales of the
book are donated to the Committee to Protect Journalists.
(Adapted from
http://home.nyc.gov/portal/index.jsp?pageID=nyc_mayor_bio&catID=119
4&cc=unused1196&rc=1194&ndi=-1)
Para responder à questão,
assinale, na folha de respostas, a letra correspondente à alternativa que preencha corretamente a
lacuna do texto apresentado (...39...).
Q2242624
Inglês
Texto associado
The hard cell
Thanks to politics, stem cell research in the United States is suffering. But not so in Sweden, which is poised to capture what could be the biggest new market to hit biotech in a decade.
By Stephan Herrera
February 13, 2003
New York, January 1, 2006:
Sweden announces that one of its biotechnology companies is the first in the world to enter clinical trials with a new drug that could cure Alzheimer's disease. Four years ago this type of research was all but stopped in the United States by political and ethical questions − which is ....61.... Sweden now seems in the best position to capture a $25 billion market.
Any day now, the U.S. Congress is expected to pass a sweeping new law that could dramatically inhibit researchers from working with stem cells taken from human embryos. Such cells, which can be used to grow a whole host of new cells and organs, could fundamentally change the way we treat heretofore intractable maladies like Alzheimer's disease, Parkinson's disease, cancer, stroke, liver failure, and heart disease. The only problem is that these cells by definition are derived from human embryos, many of which are cloned or come from unused fetuses collected at fertility clinics. The argument, from a certain segment of the American political spectrum, is that ....62.... methods are morally wrong. They are ....63.... a form of abortion or an activity that could eventually lead to human cloning.
Those working in stem cell research say the short-term effect of the legislation will be to further chill all forms of scientific inquiry and commercialization efforts in the field. Entrepreneurs and investors are already eschewing such research − in large part because of the additional uncertainty and risk that politics introduce.
Of the nearly 50 private stem cell companies in the United States, only a handful are still viable. Meanwhile, across the Atlantic, Sweden has avoided many of the political and ethical quagmires surrounding this type of research. It currently has 40 private stem cell companies, a number that's growing. Sweden's leading research universities have 32 percent of the world's stem cell inventory, close on the heels of the United States' 35 percent.
Sweden, say analysts, is now in the best position to capture a worldwide market for drugs based on stem cell therapies that could grow to $25 billion in the next three to five years − nearly equal to the whole biotech industry at present. This estimate doesn't even address the market for stem cells capable of repairing damaged vital organs like the brain, heart, and kidneys. If the United States offers an object lesson of what can happen when scientific inquiry and investment capital fall victim to politics, Sweden and its leading stem cell startup, NeuroNova, offer the opposite example. How odd that the United States, which for generations has been the envy of the world for its progressive views of science and commercialization, should now have a biomedical climate chillier than a Swedish winter.
One company feeling a lot of pain is StemCells, which at first glance seems to have it all: founding scientists include Stanford's Dr. Weissman and Fred Gage of the Salk Institute in La Jolla, California. An equally well-regarded expert in the treatment of Alzheimer's, Dr. Gage spent five years in Sweden as a researcher and now sits on a national committee on stem cell research there. The firm's chairman is Roger Perlmutter, Amgen's head of research.
Yet over the past two years, none of management's efforts to help investors and even critics reconsider the stem cell field have worked. At press time, the stock was thinly traded and sitting in the neighborhood of 50 cents. With less than $15 million in cash, the company likely won't exist at this time next year. (CEO Martin McGlynn, who joined the firm in January 2001, would not talk to Red Herring, despite repeated efforts.)
Some observers on Wall Street are asking, If StemCells can't make it, who can? Geron, the only other publicly held stem cell firm to speak of, is in a fix, too. The company's stock price is also moribund, at $3.85 per share. Thanks to some capital infusions a few years ago, when money came easy, Geron still has $40 million on hand, but by the end of next year, that too will likely be gone. Once a media darling, Geron focuses on diagnostic tests and drugs derived from stem cells, a strategy that's not going well. For the nine months ended last September, revenue fell 68 percent to $955,000 and net loss widened 18 percent to $26.7 million. The company's financials were also hit hard after it terminated an agreement with Pharmacia and acquired research technology from Lynx Therapeutics, which Geron bought in a desperate attempt to be seen as something more than just a stem cell company.
The situation is quite different, however, for Sweden's NeuroNova, which has 30 academic partners and a staff of 20. NeuroNova is working on ways to inject stem cells into the human brain to trigger a process called neurogenesis (the growth of new neural cells), which could combat diseases like Parkinson's, Alzheimer's, and even schizophrenia.
If NeuroNova is the first to develop a drug capable of treating one of several central nervous system disorders − by far the most lucrative after heart disease products − it will have done so not because it raised more money or got more media buzz than the rest. It will have succeeded because the science is solid, and academe, government, and the investment community are supportive. Meanwhile, the United States will look on with envy and wonder how it, a country known for its entrepreneurial innovation, ever got so short-sighted.
(Adapted from http://www.redherring.com/investor/2003/02/biotech021303.html)
O autor do artigo
Q2242623
Inglês
Texto associado
The hard cell
Thanks to politics, stem cell research in the United States is suffering. But not so in Sweden, which is poised to capture what could be the biggest new market to hit biotech in a decade.
By Stephan Herrera
February 13, 2003
New York, January 1, 2006:
Sweden announces that one of its biotechnology companies is the first in the world to enter clinical trials with a new drug that could cure Alzheimer's disease. Four years ago this type of research was all but stopped in the United States by political and ethical questions − which is ....61.... Sweden now seems in the best position to capture a $25 billion market.
Any day now, the U.S. Congress is expected to pass a sweeping new law that could dramatically inhibit researchers from working with stem cells taken from human embryos. Such cells, which can be used to grow a whole host of new cells and organs, could fundamentally change the way we treat heretofore intractable maladies like Alzheimer's disease, Parkinson's disease, cancer, stroke, liver failure, and heart disease. The only problem is that these cells by definition are derived from human embryos, many of which are cloned or come from unused fetuses collected at fertility clinics. The argument, from a certain segment of the American political spectrum, is that ....62.... methods are morally wrong. They are ....63.... a form of abortion or an activity that could eventually lead to human cloning.
Those working in stem cell research say the short-term effect of the legislation will be to further chill all forms of scientific inquiry and commercialization efforts in the field. Entrepreneurs and investors are already eschewing such research − in large part because of the additional uncertainty and risk that politics introduce.
Of the nearly 50 private stem cell companies in the United States, only a handful are still viable. Meanwhile, across the Atlantic, Sweden has avoided many of the political and ethical quagmires surrounding this type of research. It currently has 40 private stem cell companies, a number that's growing. Sweden's leading research universities have 32 percent of the world's stem cell inventory, close on the heels of the United States' 35 percent.
Sweden, say analysts, is now in the best position to capture a worldwide market for drugs based on stem cell therapies that could grow to $25 billion in the next three to five years − nearly equal to the whole biotech industry at present. This estimate doesn't even address the market for stem cells capable of repairing damaged vital organs like the brain, heart, and kidneys. If the United States offers an object lesson of what can happen when scientific inquiry and investment capital fall victim to politics, Sweden and its leading stem cell startup, NeuroNova, offer the opposite example. How odd that the United States, which for generations has been the envy of the world for its progressive views of science and commercialization, should now have a biomedical climate chillier than a Swedish winter.
One company feeling a lot of pain is StemCells, which at first glance seems to have it all: founding scientists include Stanford's Dr. Weissman and Fred Gage of the Salk Institute in La Jolla, California. An equally well-regarded expert in the treatment of Alzheimer's, Dr. Gage spent five years in Sweden as a researcher and now sits on a national committee on stem cell research there. The firm's chairman is Roger Perlmutter, Amgen's head of research.
Yet over the past two years, none of management's efforts to help investors and even critics reconsider the stem cell field have worked. At press time, the stock was thinly traded and sitting in the neighborhood of 50 cents. With less than $15 million in cash, the company likely won't exist at this time next year. (CEO Martin McGlynn, who joined the firm in January 2001, would not talk to Red Herring, despite repeated efforts.)
Some observers on Wall Street are asking, If StemCells can't make it, who can? Geron, the only other publicly held stem cell firm to speak of, is in a fix, too. The company's stock price is also moribund, at $3.85 per share. Thanks to some capital infusions a few years ago, when money came easy, Geron still has $40 million on hand, but by the end of next year, that too will likely be gone. Once a media darling, Geron focuses on diagnostic tests and drugs derived from stem cells, a strategy that's not going well. For the nine months ended last September, revenue fell 68 percent to $955,000 and net loss widened 18 percent to $26.7 million. The company's financials were also hit hard after it terminated an agreement with Pharmacia and acquired research technology from Lynx Therapeutics, which Geron bought in a desperate attempt to be seen as something more than just a stem cell company.
The situation is quite different, however, for Sweden's NeuroNova, which has 30 academic partners and a staff of 20. NeuroNova is working on ways to inject stem cells into the human brain to trigger a process called neurogenesis (the growth of new neural cells), which could combat diseases like Parkinson's, Alzheimer's, and even schizophrenia.
If NeuroNova is the first to develop a drug capable of treating one of several central nervous system disorders − by far the most lucrative after heart disease products − it will have done so not because it raised more money or got more media buzz than the rest. It will have succeeded because the science is solid, and academe, government, and the investment community are supportive. Meanwhile, the United States will look on with envy and wonder how it, a country known for its entrepreneurial innovation, ever got so short-sighted.
(Adapted from http://www.redherring.com/investor/2003/02/biotech021303.html)
Segundo o texto, a Geron
Q2242622
Inglês
Texto associado
The hard cell
Thanks to politics, stem cell research in the United States is suffering. But not so in Sweden, which is poised to capture what could be the biggest new market to hit biotech in a decade.
By Stephan Herrera
February 13, 2003
New York, January 1, 2006:
Sweden announces that one of its biotechnology companies is the first in the world to enter clinical trials with a new drug that could cure Alzheimer's disease. Four years ago this type of research was all but stopped in the United States by political and ethical questions − which is ....61.... Sweden now seems in the best position to capture a $25 billion market.
Any day now, the U.S. Congress is expected to pass a sweeping new law that could dramatically inhibit researchers from working with stem cells taken from human embryos. Such cells, which can be used to grow a whole host of new cells and organs, could fundamentally change the way we treat heretofore intractable maladies like Alzheimer's disease, Parkinson's disease, cancer, stroke, liver failure, and heart disease. The only problem is that these cells by definition are derived from human embryos, many of which are cloned or come from unused fetuses collected at fertility clinics. The argument, from a certain segment of the American political spectrum, is that ....62.... methods are morally wrong. They are ....63.... a form of abortion or an activity that could eventually lead to human cloning.
Those working in stem cell research say the short-term effect of the legislation will be to further chill all forms of scientific inquiry and commercialization efforts in the field. Entrepreneurs and investors are already eschewing such research − in large part because of the additional uncertainty and risk that politics introduce.
Of the nearly 50 private stem cell companies in the United States, only a handful are still viable. Meanwhile, across the Atlantic, Sweden has avoided many of the political and ethical quagmires surrounding this type of research. It currently has 40 private stem cell companies, a number that's growing. Sweden's leading research universities have 32 percent of the world's stem cell inventory, close on the heels of the United States' 35 percent.
Sweden, say analysts, is now in the best position to capture a worldwide market for drugs based on stem cell therapies that could grow to $25 billion in the next three to five years − nearly equal to the whole biotech industry at present. This estimate doesn't even address the market for stem cells capable of repairing damaged vital organs like the brain, heart, and kidneys. If the United States offers an object lesson of what can happen when scientific inquiry and investment capital fall victim to politics, Sweden and its leading stem cell startup, NeuroNova, offer the opposite example. How odd that the United States, which for generations has been the envy of the world for its progressive views of science and commercialization, should now have a biomedical climate chillier than a Swedish winter.
One company feeling a lot of pain is StemCells, which at first glance seems to have it all: founding scientists include Stanford's Dr. Weissman and Fred Gage of the Salk Institute in La Jolla, California. An equally well-regarded expert in the treatment of Alzheimer's, Dr. Gage spent five years in Sweden as a researcher and now sits on a national committee on stem cell research there. The firm's chairman is Roger Perlmutter, Amgen's head of research.
Yet over the past two years, none of management's efforts to help investors and even critics reconsider the stem cell field have worked. At press time, the stock was thinly traded and sitting in the neighborhood of 50 cents. With less than $15 million in cash, the company likely won't exist at this time next year. (CEO Martin McGlynn, who joined the firm in January 2001, would not talk to Red Herring, despite repeated efforts.)
Some observers on Wall Street are asking, If StemCells can't make it, who can? Geron, the only other publicly held stem cell firm to speak of, is in a fix, too. The company's stock price is also moribund, at $3.85 per share. Thanks to some capital infusions a few years ago, when money came easy, Geron still has $40 million on hand, but by the end of next year, that too will likely be gone. Once a media darling, Geron focuses on diagnostic tests and drugs derived from stem cells, a strategy that's not going well. For the nine months ended last September, revenue fell 68 percent to $955,000 and net loss widened 18 percent to $26.7 million. The company's financials were also hit hard after it terminated an agreement with Pharmacia and acquired research technology from Lynx Therapeutics, which Geron bought in a desperate attempt to be seen as something more than just a stem cell company.
The situation is quite different, however, for Sweden's NeuroNova, which has 30 academic partners and a staff of 20. NeuroNova is working on ways to inject stem cells into the human brain to trigger a process called neurogenesis (the growth of new neural cells), which could combat diseases like Parkinson's, Alzheimer's, and even schizophrenia.
If NeuroNova is the first to develop a drug capable of treating one of several central nervous system disorders − by far the most lucrative after heart disease products − it will have done so not because it raised more money or got more media buzz than the rest. It will have succeeded because the science is solid, and academe, government, and the investment community are supportive. Meanwhile, the United States will look on with envy and wonder how it, a country known for its entrepreneurial innovation, ever got so short-sighted.
(Adapted from http://www.redherring.com/investor/2003/02/biotech021303.html)
De acordo com o texto,
Q2242612
Inglês
Texto associado
From the IPO to the First Trade: Is Underpricing Related to the Trading Mechanism?
Sonia Falconieri, Albert Murphy and Daniel Weaver
As documented by a vast empirical literature, IPOs are characterized by underpricing. Most of the theoretical literature has linked the size of underpricing to the IPO procedure used on the primary market. In this paper, by using a matched sample of NYSE and Nasdaq IPOs, we show that the size of underpricing also depends on the trading method used in the IPO aftermarket.
There are two major methods of opening trading of initial public offerings (IPOs) in the U.S. The NYSE is an order-driven market ....56.... a call auction allows supply and demand to be aggregated (at one location) prior to the start of trading. ....57.... , Nasdaq is a quote-driven market. Dealers can only specify their best quotes, and participants have ....58.... idea of supply and demand away from the inside quotes.
We propose a new proxy for ex ante uncertainty of firm value and test it. Our results show that there is a larger level of uncertainty at the beginning of trading on Nasdaq than on the NYSE. This in turn is associated with larger levels of underpricing for Nasdaq IPOs. We suggest that this may be due to the different informational efficiency of the two trading systems.
(http://www.nyse.com/marketinfo/p1020656068262.html?displayPage=% 2Fmarketinfo%2Fmarketinfo.html)
Para responder à questão, assinale, na folha de respostas, a letra correspondente à alternativa que preenche corretamente a lacuna do texto apresentado (....57....).
Q2242600
Português
Texto associado
A compensação
Não faz muito, li um artigo sobre as pretensões literárias
de Napoleão Bonaparte. Aparentemente, Napoleão era um
escritor frustrado. Tinha escrito contos e poemas na juventude,
escreveu muito sobre política e estratégia militar, e sonhava em
escrever um grande romance. Acreditava-se, mesmo, que
Napoleão considerava a literatura sua verdadeira vocação, e
que foi sua incapacidade de escrever um grande romance e
conquistar uma reputação literária que o levou a escolher uma
alternativa menor, conquistar o mundo.
Não sei se é verdade, mas fiquei pensando no que isto
significa para os escritores de hoje e daqui. Em primeiro lugar,
claro, leva a pensar na enorme importância que tinha a literatura
nos séculos XVIII e XIX, e não apenas na França, onde,
anos depois de Napoleão Bonaparte, um Victor Hugo
empolgaria multidões e faria história não com batalhas e
canhões, mas com a força da palavra escrita, e não só em
conclamações e panfletos, mas, muitas vezes, na forma de
ficção. Não sei se devemos invejar uma época em que
reputações literárias e reputações guerreiras se equivaliam
desta maneira, e em que até a imaginação tinha tanto poder.
Mas acho que podemos invejar, pelo menos um pouco, o que a
literatura tinha então e parece ter perdido: relevância. Se
Napoleão pensava que podia ser tão relevante escrevendo
romances quanto comandando exércitos, e se um Victor Hugo
podia morrer como um dos homens mais relevantes do seu
tempo sem nunca ter trocado a palavra e a imaginação por
armas, então uma pergunta que nenhum escritor daquele tempo
se fazia é essa que nos fazemos o tempo todo: para que serve
a literatura, de que adianta a palavra impressa, onde está a
nossa relevância? Gostávamos de pensar que era através dos
seus escritores e intelectuais que o mundo se pensava e se
entendia, e a experiência humana era racionalizada. O estado
irracional do mundo neste começo de século é a medida do
fracasso desta missão, ou desta ilusão.
Depois que a literatura deixou de ser uma opção tão
vigorosa e vital para um homem de ação quanto a conquista
militar ou política – ou seja, depois que virou opção para
generais e políticos aposentados, mais compensação pela
perda de poder do que poder, e uma ocupação para, enfim,
meros escritores – ela nunca mais recuperou a sua respeitabilidade, na medida em que qualquer poder, por armas ou por
palavras, é respeitável. Hoje a literatura só participa da política,
do poder e da história como instrumento ou cúmplice. E não
pode nem escolher que tipo de cúmplice quer ser. Todos os que
escrevem no Brasil, principalmente os que têm um espaço na
imprensa para fazer sua pequena literatura ou simplesmente
dar seus palpites, têm esta preocupação. Ou deveriam ter. (...)
(Luiz Fernando Veríssimo, Banquete com os deuses. Rio de
Janeiro: Objetiva, 2003, pp. 113-14)
Está clara e correta a articulação entre os tempos verbais
na seguinte frase:
Q2242580
Auditoria
Assinale a alternativa correta, em relação à revisão
externa da auditoria pelos pares, segundo as Normas
Brasileiras de Contabilidade.
Q2242578
Auditoria
A carta de responsabilidade da administração quanto às
informações e dados, bem como à preparação e apresentação das demonstrações contábeis submetidas à auditoria, deve ser emitida com a mesma data
Q2242577
Auditoria
A técnica conhecida como circularização se enquadra no
procedimento básico de auditoria denominado
Q2242576
Auditoria
O conjunto dos papéis de trabalho do auditor
independente, de acordo com as Normas Brasileiras de
Contabilidade, deve ser guardado pelo prazo de
Conheça nossos planos